Crossmark

Should daptomycin–rifampin combinations for MSSA/MRSA isolates be avoided because of antagonism?

Crossref DOI link: https://doi.org/10.1007/s15010-016-0874-2

Published Online: 2016-01-21

Published Print: 2016-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Stein, C.

Makarewicz, O.

Forstner, C.

Weis, S.

Hagel, S.

Löffler, B.

Pletz, M. W. https://orcid.org/0000-0001-8157-2753
Funding

Funding for this research was provided by:

German Ministry of Education and Research (01KI1204)

ARGUS-Stiftung
License Information

Text and Data Mining valid from 2016-01-21